Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

SpartanNash Q2 Net Sales Rise 1.8%

SpartanNash has reported its financial results for the second quarter ended July 12, 2025, highlighting a 1.8% increase in net sales to $2.27 billion. In the wholesale segment, net sales decreased by 3.0% to $1.51 billion, primarily due to reduced case volumes in the national accounts customer channel. However, the retail segment saw a 12.8% increase in net sales to $762.9 million due to incremental sales from recently acquired stores.

Net earnings were reported at $6.2 million or $0.18 per diluted share, compared to $11.5 million or $0.34 per diluted share in the same period last year. Adjusted EPS stood at $0.54, compared to $0.59. Adjusted EBITDA for the quarter was $68.7 million, showing an improvement from $64.5 million in the previous year.

Cash generated from operating activities was $112.6 million, down from $132.1 million in the same period last year. The net long-term debt to adjusted EBITDA ratio improved to 2.7x from 2.9x in the first quarter of 2025. Additionally, the company returned $15.5 million to shareholders through dividends.

Looking ahead, SpartanNash will not host a quarterly earnings conference call and will not provide fiscal 2025 financial guidance due to the pending transaction with C&S Wholesale Grocers, LLC. The transaction, in which C&S will acquire SpartanNash for a purchase price of $26.90 per share in cash, representing total consideration of $1.77 billion, is expected to close in late 2025.

As of the end of the second quarter of 2025, SpartanNash operates nearly 200 brick-and-mortar grocery stores and has a global supply chain network that serves wholesale customers including independent and chain grocers, national retail brands, e-commerce platforms, and U.S. military commissaries and exchanges. The market has reacted to these announcements by moving the company's shares 0.0% to a price of $26.56. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS